Aktiespot

Canopy Growth Corporation Aktie

CGC

$1.0600-0.0200 (-1.85%)
Chart wird geladen...
Canopy Growth Corporation Logo

Canopy Growth Corporation

Eröffnung1.0700
Hoch1.0800
Tief1.0600
Volumen6.26M
P/EN/A
Marktkapitalisierung476.03M
52-Wochen-Hoch2.3800
52-Wochen-Tief0.8440
Durchschn. Volumen9.94M
DividendeN/A
Beta2.39
EPS-1.3500

Über Canopy Growth Corporation Aktie

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Unternehmensinformationen

Börse: NasdaqGS (NMS)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
1 Hershey Drive
K7A 0A8 Smiths Falls, Canada
Telefon: + 855 558 9333

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
1.77
67.2%
Durchschnittliches Kursziel
1.77
67.2%
Median Kursziel
1.77
67.2%
Höchstes Kursziel
1.77
67.2%

Andere sehen auch: